1. Home
  2. News
  3. Vectus Biosystems Limited
  4. Completion of Second M.A.D. Study for VB0004
More Vectus Biosystems Limited news
Vectus Biosystems LimitedASX: VBS

Completion of Second M.A.D. Study for VB0004

Aug 8, 2022 at 12:33 AM EDT · Issued by Vectus Biosystems Limited

Filed with ASX · Aug 8, 2022 at 12:33 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/completion-of-second-mad-study-for-vb0004

Vectus Biosystems Limited on 6ix

Story so far

  • Completion of Final S.A.D. Study and First M.A.D. StudyMay 25, 2022

Earlier from Vectus Biosystems

  • Quarterly Activities Report & Appendix 4CJul 28, 2022
  • Completion of Final S.A.D. Study and First M.A.D. StudyMay 25, 2022
  • Half Yearly Report and Appendix 4DFeb 25, 2022
  • A Significant Milestone for VB0004Feb 20, 2022
  • Chairman & CEO Address to ShareholdersJan 24, 2022

Later from Vectus Biosystems

  • Completion of Phase Ia for VB0004Sep 14, 2022
  • Vectus - $3.5 million placementNov 22, 2022
  • Issue Of Shares Under PlacementDec 1, 2022
  • Half Yearly Report & Appendix 4DFeb 24, 2023
  • Preliminary Final Report - Appendix 4EAug 30, 2023
All Vectus Biosystems news releases↗

Follow Vectus Biosystems into a list and get an email when it puts out news.

Follow Vectus Biosystems
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer